Related Experiment Video
Updated: Oct 14, 2025
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Metabolic and inflammatory functions of cannabinoid receptor type 1 are differentially modulated by adiponectin
Qiong Wei1, Jong Han Lee2, Chia-Shan Wu2
1Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China.
Background:
Antagonists of cannabinoid type 1 receptor (CB1) have been shown to promote body weight loss and improve insulin sensitivity. Cannabinoids decrease adiponectin, and CB1 blocker increase adiponectin. However, the mediators of CB1 actions are not well defined.
Aim:
To investigate whether the beneficial effects of CB1 inhibition are, at least in part, mediated by adiponectin.
Methods:
We compared metabolic and inflammatory phenotypes of wild-type (WT) mice, CB1-null (CB1 -/-) and CB1/adiponectin double-knockout (DKO) mice. We assessed the insulin sensitivity using insulin tolerance test and glucose tolerance test, and inflammation using flow cytometry analysis of macrophages.
Results:
CB1 -/- mice exhibited significantly reduced body weight and fat mass when compared to WT mice. While no significance was found in total daily food intake and locomotor activity, CB1 -/- mice showed increased energy expenditure, enhanced thermogenesis in brown adipose tissue (BAT), and improved insulin sensitivity compared to WT mice. DKO showed no difference in body weight, adiposity, nor insulin sensitivity; only showed a modestly elevated thermogenesis in BAT compared to CB1 -/- mice. The metabolic phenotype of DKO is largely similar to CB1 -/- mice, suggesting that adiponectin is not a key mediator of the metabolic effects of CB1. Interestingly, CB1 -/- mice showed reduced pro-inflammatory macrophage polarization in both peritoneal macrophages and adipose tissue macrophages compared to WT mice; in contrast, DKO mice exhibited increased pro-inflammatory macrophage polarization in these macrophages compared to CB1 -/- mice, suggesting that adiponectin is an important mediator of the inflammatory effect of CB1.
Conclusion:
Our findings reveal that CB1 functions through both adiponectin-dependent and adiponectin-independent mechanisms: CB1 regulates energy metabolism in an adiponectin-independent manner, and inflammation in an adiponectin-dependent manner. The differential effects of adiponectin on CB1-mediated metabolic and inflammatory functions should be taken into consideration in CB1 antagonist utilization.
Insights
Cannabinoid type 1 receptor (CB1) inhibition impacts energy metabolism independently of adiponectin but influences inflammation in an adiponectin-dependent manner. These findings are crucial for developing CB1 antagonist therapies.
Area of Science:
- Metabolic and inflammatory signaling pathways.
- Endocannabinoid system research.
- Adipose tissue biology and function.
Background:
- Cannabinoid type 1 receptor (CB1) antagonists promote weight loss and improve insulin sensitivity.
- CB1 receptor activity influences adiponectin levels, but its mediators remain unclear.
- Understanding CB1's downstream effects is critical for therapeutic applications.
Purpose of the Study:
- To determine if adiponectin mediates the metabolic and inflammatory effects of CB1 inhibition.
- To elucidate the distinct roles of CB1 signaling in energy balance and immune response.
Main Methods:
- Comparative analysis of wild-type, CB1-null, and CB1/adiponectin double-knockout mice.
- Assessment of insulin sensitivity via glucose and insulin tolerance tests.
- Evaluation of macrophage polarization using flow cytometry.
Main Results:
- CB1-null mice showed reduced body weight, fat mass, and improved insulin sensitivity compared to wild-type mice.
- Metabolic improvements in CB1-null mice were largely independent of adiponectin, as seen in double-knockout mice.
- CB1 inhibition reduced pro-inflammatory macrophages, an effect dependent on adiponectin.
Conclusions:
- CB1 regulates energy metabolism independently of adiponectin.
- CB1 influences inflammation through an adiponectin-dependent pathway.
- Adiponectin's differential role in CB1's metabolic versus inflammatory actions requires consideration for CB1 antagonist therapies.
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:30Regulation of Food Intake
01:26Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
01:28Insulin: The Receptor and Signaling Pathways
01:28Global Regulatory Systems